Id1-4 genes, previously implicated as mediators of TGF-β signaling and metabolic reprogramming in cancer models, including HCC, were increased in high iron group, as compared to low iron FF group [32,33]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.